- $183.19m
- $185.29m
- 16
- 69
- 13
- 24
Annual income statement for CONX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | — | 0.162 | 0.555 | 0.889 | 1.18 |
| Operating Profit | 0 | -0.162 | -0.555 | -0.889 | -1.18 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | — | 2.12 | 19.4 | 25.4 | -5.93 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | — | 2.12 | 19.4 | 24.2 | -5.99 |
| Net Income Before Extraordinary Items | |||||
| Net Income | — | 2.12 | 19.4 | 24.2 | -5.99 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 0 | 2.12 | 19.4 | 24.2 | -5.99 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | — | 0.023 | 0.206 | 0.292 | -0.252 |
| Dividends per Share |